Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.
The report details the trend, potential and market size of Hereditary Angioedema market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hereditary Angioedemamarket, defines the market attractiveness level of Hereditary Angioedema market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hereditary Angioedema industry, describes the types of Hereditary Angioedema market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hereditary Angioedema market and the development prospects and opportunities of Hereditary Angioedema industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hereditary Angioedema market in Chapter 13.
By Player:
Pharming Group NV
Shire plc
CSL Limited
By Type:
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By End-User:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hereditary Angioedema Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hereditary Angioedema Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hereditary Angioedema Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hereditary Angioedema Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hereditary Angioedema Market Analysis and Outlook to 2022
-
7.1 Global Hereditary Angioedema Consumption (2017-2022)
-
7.2 United States Hereditary Angioedema Consumption (2017-2022)
-
7.3 Europe Hereditary Angioedema Consumption (2017-2022)
-
7.4 China Hereditary Angioedema Consumption (2017-2022)
-
7.5 Japan Hereditary Angioedema Consumption (2017-2022)
-
7.6 India Hereditary Angioedema Consumption (2017-2022)
-
7.7 South Korea Hereditary Angioedema Consumption (2017-2022)
8 Region and Country-wise Hereditary Angioedema Market Analysis and Outlook to 2028
-
8.1 Global Hereditary Angioedema Consumption Forecast (2022-2028)
-
8.2 United States Hereditary Angioedema Consumption Forecast (2022-2028)
-
8.3 Europe Hereditary Angioedema Consumption Forecast (2022-2028)
-
8.4 China Hereditary Angioedema Consumption Forecast (2022-2028)
-
8.5 Japan Hereditary Angioedema Consumption Forecast (2022-2028)
-
8.6 India Hereditary Angioedema Consumption Forecast (2022-2028)
-
8.7 South Korea Hereditary Angioedema Consumption Forecast (2022-2028)
9 Global Hereditary Angioedema Market Outlook by Types and Applications to 2022
-
9.1 Global Hereditary Angioedema Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global C1 Esterase Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Kallikrein Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Selective Bradykinin B2 Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
9.2 Global Hereditary Angioedema Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Hereditary Angioedema Market Outlook by Types and Applications to 2028
-
10.1 Global Hereditary Angioedema Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global C1 Esterase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Kallikrein Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Selective Bradykinin B2 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hereditary Angioedema Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Hereditary Angioedema Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hereditary Angioedema Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hereditary Angioedema Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hereditary Angioedema Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hereditary Angioedema Market Competitive Analysis
-
14.1 Pharming Group NV
-
14.1.1 Pharming Group NV Company Details
-
14.1.2 Pharming Group NV Hereditary Angioedema Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pharming Group NV Hereditary Angioedema Product and Service
-
14.2 Shire plc
-
14.2.1 Shire plc Company Details
-
14.2.2 Shire plc Hereditary Angioedema Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shire plc Hereditary Angioedema Product and Service
-
14.3 CSL Limited
-
14.3.1 CSL Limited Company Details
-
14.3.2 CSL Limited Hereditary Angioedema Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 CSL Limited Hereditary Angioedema Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hereditary Angioedema
-
Figure Hereditary Angioedema Picture
-
Table Global Hereditary Angioedema Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hereditary Angioedema Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hereditary Angioedema Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hereditary Angioedema Consumption by Country (2017-2022)
-
Figure United States Hereditary Angioedema Consumption and Growth Rate (2017-2022)
-
Table Europe Hereditary Angioedema Consumption and Growth Rate (2017-2022)
-
Figure China Hereditary Angioedema Consumption and Growth Rate (2017-2022)
-
Figure Japan Hereditary Angioedema Consumption and Growth Rate (2017-2022)
-
Figure India Hereditary Angioedema Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hereditary Angioedema Consumption and Growth Rate (2017-2022)
-
Figure Global Hereditary Angioedema Consumption Forecast by Country (2022-2028)
-
Figure United States Hereditary Angioedema Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hereditary Angioedema Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hereditary Angioedema Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hereditary Angioedema Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hereditary Angioedema Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hereditary Angioedema Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global C1 Esterase Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Kallikrein Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Selective Bradykinin B2 Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global C1 Esterase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kallikrein Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Selective Bradykinin B2 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hereditary Angioedema Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hereditary Angioedema Export by Region (Top 5 Countries) (2017-2028)
-
Table Pharming Group NV (Foundation Year, Company Profile and etc.)
-
Table Pharming Group NV Hereditary Angioedema Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharming Group NV Hereditary Angioedema Product and Service
-
Table Shire plc (Foundation Year, Company Profile and etc.)
-
Table Shire plc Hereditary Angioedema Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire plc Hereditary Angioedema Product and Service
-
Table CSL Limited (Foundation Year, Company Profile and etc.)
-
Table CSL Limited Hereditary Angioedema Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Hereditary Angioedema Product and Service
-
